Pharmaceutical aerosol composition

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/12 (2006.01) A61K 31/58 (2006.01) A61K 38/13 (2006.01) A61M 15/00 (2006.01) A61P 11/00 (2006.01) A61P 37/02 (2006.01)

Patent

CA 2604327

Sterile compositions for administration as aerosols are described. They contain an active agent which is poorly water-soluble, a non-ionic surfactant component and a phospholipid component. The compositions are suitable for oral or nasal inhalation, but also for topical or oromucosal administration. They are particulary useful for the efficient pulmonary administration of poorly soluble corticosteroids and can be aerosolized with common nebulizers.

La présente invention a trait à des compositions stériles pour administration sous forme d'aérosols. Elles contiennent un principe actif qui est très peu hydrosoluble, un constituant tensioactif non ionique et un constituant phospholipidique. Les compositions conviennent à l'inhalation orale ou nasale, mais également pour une administration topique ou oromucosale. Elles sont particulièrement utiles pour une administration pulmonaire efficace de corticostéroïdes et peuvent être formulées sous forme d'aérosol avec des nébuliseurs classiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical aerosol composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical aerosol composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical aerosol composition will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1655875

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.